Run, forward!
Release time:
2020-08-14
Run!
11# May 4 , the sky in Tianjin Economic and Technological Development Zone is blue. Although there is a bitter early winter in the air, the people in the square of TEDA MSD are enthusiastic. Because, the third Teda National Marathon is about to start here.
The theme of this competition is "Tai Xiang runs with you". Two events have been set up: "10 km Marathon Time Trial" and "5 km Colorful Run". The purpose is to encourage participants to overcome difficulties and mobilize citizens' enthusiasm for happy sports. Moreover, the openness of this competition is higher than that of previous competitions. In addition to groups and individuals within the development zones, people from non-development zones can also sign up, so there are nearly 17 5000 18 applicants. We, Tianjin Jianfeng Flanders Pharmaceutical Technology Development Co., Ltd., have also organized teams of 8 and 16 to participate in the above two projects, including both employees of the company, their families and friends of Jianfeng Flanders. Under the banner of the peak, we let the citizens of TEDA really feel the elegant demeanor of our peak people "determined to rise to the top and climb the peak forever" and the spirit of unity and upward and not afraid of difficulties. at
o'clock in the morning, the check-in began. under the guidance of the unit sign, everyone dressed in sportswear and with a number plate on their chests began to warm up eagerly. With the crisp starting gun, General Manager Wei Hongjun took the 10 km team to start first. 10 minutes later, deputy general manager Wang Wei set off with a colorful team of 5 kilometers. The competition starts from square MSD in TEDA core area, passes through residential and industrial areas, and returns to the original road. Running requires not only speed and passion, but also good physical fitness and perseverance. As time went on, the runners who gathered at the start gradually pulled away. Some of the young people who initially rushed ahead lacked stamina and gradually slowed down their pace. Because our Flanders usually pay attention to physical exercise, the results were shown heartily in this competition. The teammates encouraged each other, adjusted their breathing while running unhurriedly, and the trees and buildings on the roadside were quickly left behind.
52
10 km contestant reached the finish line. 79
10 km players all finished the race. General Manager Wei Hongjun said that in the summer of
in Jinhua, he had hiked on the Wujiang embankment with Jiang Xiaomeng, chairman of the group company, which was the beginning of his fitness exercise. Sports, like our work and our life, need to run hard, need to have enough patience, need to have the courage to overcome difficulties. Through this "review" of "Taima", our Jianfeng Flanders team has strengthened its confidence to meet the challenge and achieve its goals. After the competition, everyone will meet. Goodbye to "Thai Horse" next year! (Liu Hairong)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page